BGM1812

· BrightGene Bio-Medical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BGM1812, covering 2025-11-06 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study of BGM1812 Injection in Healthy and Non-diabetic Overweight or Obese Chinese Participants [Phase 1]